Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #010
mi
from
Boston, MA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #010
mi
from
Boston, MA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 025
mi
from
St. Louis, MO
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 025
mi
from
St. Louis, MO
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #011
mi
from
Staten Island, NY
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #011
mi
from
Staten Island, NY
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 019
mi
from
Philadelphia, PA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 019
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Dallas, TX
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 101
mi
from
Kelowna,
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 101
mi
from
Kelowna,
Click here to add this to my saved trials
Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression
Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.
Status: Enrolling
Updated:  2/7/2012
University of California at Los Angeles
mi
from
Los Angeles, CA
Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression
Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.
Status: Enrolling
Updated: 2/7/2012
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression
Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.
Status: Enrolling
Updated:  2/7/2012
Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany
mi
from
Berlin,
Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression
Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.
Status: Enrolling
Updated: 2/7/2012
Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany
mi
from
Berlin,
Click here to add this to my saved trials
Low Field Magnetic Stimulation Treatment for Bipolar Depression
Low Field Magnetic Stimulation in Bipolar Depression
Status: Enrolling
Updated:  3/13/2012
McLean Hospital
mi
from
Belmont, MA
Low Field Magnetic Stimulation Treatment for Bipolar Depression
Low Field Magnetic Stimulation in Bipolar Depression
Status: Enrolling
Updated: 3/13/2012
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Effects of Electroconvulsive Therapy (ECT) in Bipolar Depression
A Study of the Acute and Chronic Effects of Electroconvulsive Therapy on Glutamatergic Neurotransmission in Bipolar Depression
Status: Enrolling
Updated:  3/16/2012
McLean Hospital
mi
from
Belmont, MA
Effects of Electroconvulsive Therapy (ECT) in Bipolar Depression
A Study of the Acute and Chronic Effects of Electroconvulsive Therapy on Glutamatergic Neurotransmission in Bipolar Depression
Status: Enrolling
Updated: 3/16/2012
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Pioglitazone in Patients With Mood Disorders
Pioglitazone Treatment for Insulin Resistant Patients With Mood Disorders
Status: Enrolling
Updated:  3/19/2012
Stanford University Department of Psychiatry & Behavioral Sciences
mi
from
Palo Alto, CA
Pioglitazone in Patients With Mood Disorders
Pioglitazone Treatment for Insulin Resistant Patients With Mood Disorders
Status: Enrolling
Updated: 3/19/2012
Stanford University Department of Psychiatry & Behavioral Sciences
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Status: Enrolling
Updated:  3/21/2012
Yale University
mi
from
New Haven, CT
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Status: Enrolling
Updated: 3/21/2012
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Status: Enrolling
Updated:  3/21/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Status: Enrolling
Updated: 3/21/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Status: Enrolling
Updated:  3/21/2012
Massachusetts General Hospital
mi
from
Boston, MA
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Status: Enrolling
Updated: 3/21/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Status: Enrolling
Updated:  3/21/2012
Baylor College of Medicine
mi
from
Houston, TX
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression
Status: Enrolling
Updated: 3/21/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Testing the Effectiveness of a Computer-based Program for Depression
Attention Training for Major Depressive Disorder
Status: Enrolling
Updated:  3/26/2012
University of Texas at Austin
mi
from
Austin, TX
Testing the Effectiveness of a Computer-based Program for Depression
Attention Training for Major Depressive Disorder
Status: Enrolling
Updated: 3/26/2012
University of Texas at Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Ketamine Anesthesia in Electroconvulsive Therapy
A Randomized Comparison of Ketamine and Methohexital Anesthesia for ECT in Depression
Status: Enrolling
Updated:  3/29/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Ketamine Anesthesia in Electroconvulsive Therapy
A Randomized Comparison of Ketamine and Methohexital Anesthesia for ECT in Depression
Status: Enrolling
Updated: 3/29/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Depression and Self-care in Heart Failure
Treatment of Functional Impairment in Patients With Heart Failure and Comorbid Depression
Status: Enrolling
Updated:  4/2/2012
Washington University School of Medicine Behavioral Medicine Center
mi
from
St. Louis, MO
Depression and Self-care in Heart Failure
Treatment of Functional Impairment in Patients With Heart Failure and Comorbid Depression
Status: Enrolling
Updated: 4/2/2012
Washington University School of Medicine Behavioral Medicine Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram
Adjunctive Creatine Treatment for Adolescent Females With Major Depressive Disorder Who Are Non-Responders to Fluoxetine or Escitalopram: A Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated:  4/19/2012
University of Utah
mi
from
Salt Lake City, UT
Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram
Adjunctive Creatine Treatment for Adolescent Females With Major Depressive Disorder Who Are Non-Responders to Fluoxetine or Escitalopram: A Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated: 4/19/2012
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease
Increasing Access and Implementation of Behavioral Treatments for Anxiety and Depression in Rural Veterans With Parkinson's Disease
Status: Enrolling
Updated:  4/20/2012
Michael E. DeBakey Veteran Affairs Medical Center
mi
from
Houston, TX
Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease
Increasing Access and Implementation of Behavioral Treatments for Anxiety and Depression in Rural Veterans With Parkinson's Disease
Status: Enrolling
Updated: 4/20/2012
Michael E. DeBakey Veteran Affairs Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Dichotic Listening as a Predictor of Medication Response in Depression
Dichotic Listening as a Predictor of Placebo and Medication Response in Depression
Status: Enrolling
Updated:  4/26/2012
Depression Evaluation Service - New York State Psychiatric Institute
mi
from
New York, NY
Dichotic Listening as a Predictor of Medication Response in Depression
Dichotic Listening as a Predictor of Placebo and Medication Response in Depression
Status: Enrolling
Updated: 4/26/2012
Depression Evaluation Service - New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Focal Electroconvulsive Therapy for Depression
Focal Electrical Administered Seizure Therapy (FEAST) for Major Depression
Status: Enrolling
Updated:  4/29/2012
Medical University of South Carolina
mi
from
Charleston, SC
Focal Electroconvulsive Therapy for Depression
Focal Electrical Administered Seizure Therapy (FEAST) for Major Depression
Status: Enrolling
Updated: 4/29/2012
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
Comparative Risks for Insulin Resistance and Metabolic Syndrome (MS) Among Hospitalized Patients With Major Depressive Disorder With (MDpsy) or Without (MDD) Psychotic Features
Status: Enrolling
Updated:  4/30/2012
Massachusetts General Hospital
mi
from
Boston, MA
Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
Comparative Risks for Insulin Resistance and Metabolic Syndrome (MS) Among Hospitalized Patients With Major Depressive Disorder With (MDpsy) or Without (MDD) Psychotic Features
Status: Enrolling
Updated: 4/30/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Psychosocial Treatment of Depression in Parkinson's Disease
Psychosocial Treatment of Depression in Parkinson's Disease
Status: Enrolling
Updated:  5/2/2012
Massachusetts General Hospital
mi
from
Boston, MA
Psychosocial Treatment of Depression in Parkinson's Disease
Psychosocial Treatment of Depression in Parkinson's Disease
Status: Enrolling
Updated: 5/2/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations
A Randomized Controlled Study of Mind-Body Skills Groups for Treatment of War Zone Stress in Military and Veteran Populations
Status: Enrolling
Updated:  5/7/2012
Southeast Louisiana Veterans Healthcare System
mi
from
New Orleans, LA
Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations
A Randomized Controlled Study of Mind-Body Skills Groups for Treatment of War Zone Stress in Military and Veteran Populations
Status: Enrolling
Updated: 5/7/2012
Southeast Louisiana Veterans Healthcare System
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study of Technology-assisted Treatment of Adolescent Depression
Information Technology Enabled Treatment of Adolescent Depression
Status: Enrolling
Updated:  5/8/2012
University of Connecticut Health Center
mi
from
Farmington, CT
Study of Technology-assisted Treatment of Adolescent Depression
Information Technology Enabled Treatment of Adolescent Depression
Status: Enrolling
Updated: 5/8/2012
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Study of Technology-assisted Treatment of Adolescent Depression
Information Technology Enabled Treatment of Adolescent Depression
Status: Enrolling
Updated:  5/8/2012
Woburn Pediatric Associates
mi
from
Woburn, MA
Study of Technology-assisted Treatment of Adolescent Depression
Information Technology Enabled Treatment of Adolescent Depression
Status: Enrolling
Updated: 5/8/2012
Woburn Pediatric Associates
mi
from
Woburn, MA
Click here to add this to my saved trials
Exercise in Treatment Resistant Depression (TRD): A Feasibility Study
Clinical and Neuroendocrine/Metabolic Benefits of Exercise in Treatment Resistant Depression (TRD): A Feasibility Study
Status: Enrolling
Updated:  5/11/2012
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Exercise in Treatment Resistant Depression (TRD): A Feasibility Study
Clinical and Neuroendocrine/Metabolic Benefits of Exercise in Treatment Resistant Depression (TRD): A Feasibility Study
Status: Enrolling
Updated: 5/11/2012
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Preventing Mid- and Later-Life Work Limitations
Preventing Mid- and Later-Life Work Limitations: Community-Based Depression Care
Status: Enrolling
Updated:  5/30/2012
Tufts Medical Center
mi
from
Boston, MA
Preventing Mid- and Later-Life Work Limitations
Preventing Mid- and Later-Life Work Limitations: Community-Based Depression Care
Status: Enrolling
Updated: 5/30/2012
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Glutathione and Health With Post-Polio Syndrome
Oral Glutathione and Health Outcomes Among Persons With Post-Polio Syndrome
Status: Enrolling
Updated:  6/8/2012
University of Michigan
mi
from
Ann Arbor, MI
Glutathione and Health With Post-Polio Syndrome
Oral Glutathione and Health Outcomes Among Persons With Post-Polio Syndrome
Status: Enrolling
Updated: 6/8/2012
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Practicing Alternative Techniques to Heal From Depression: The PATH-D Study
Applying Mindfulness-Based Cognitive Therapy to Treatment-Resistant Depression
Status: Enrolling
Updated:  6/12/2012
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Practicing Alternative Techniques to Heal From Depression: The PATH-D Study
Applying Mindfulness-Based Cognitive Therapy to Treatment-Resistant Depression
Status: Enrolling
Updated: 6/12/2012
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Click here to add this to my saved trials
inMotion Clinical Study: Using Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI
The Effectiveness of Physical Activity for Major Depression in People Aging With Multiple Sclerosis or Spinal Cord Injury
Status: Enrolling
Updated:  6/19/2012
University of Washington
mi
from
Seattle, WA
inMotion Clinical Study: Using Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI
The Effectiveness of Physical Activity for Major Depression in People Aging With Multiple Sclerosis or Spinal Cord Injury
Status: Enrolling
Updated: 6/19/2012
University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Ocular Hypertension And Yoga Study
Ocular Hypertension And Yoga Study
Status: Enrolling
Updated:  6/20/2012
Lions Vision and Research Rehabilitation
mi
from
Baltimore, MD
Ocular Hypertension And Yoga Study
Ocular Hypertension And Yoga Study
Status: Enrolling
Updated: 6/20/2012
Lions Vision and Research Rehabilitation
mi
from
Baltimore, MD
Click here to add this to my saved trials
PET Biomarkers in Treatment Resistant Depression
Developing a Biomarker to Predict Response in Treatment Resistant Depression
Status: Enrolling
Updated:  6/26/2012
New York State Psychiatric Institute
mi
from
New York, NY
PET Biomarkers in Treatment Resistant Depression
Developing a Biomarker to Predict Response in Treatment Resistant Depression
Status: Enrolling
Updated: 6/26/2012
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Improving Care of Patients With Heart Failure
A Randomized Controlled Trial for Patients With Heart Failure
Status: Enrolling
Updated:  6/26/2012
UCSF Medical Center
mi
from
San Francisco, CA
Improving Care of Patients With Heart Failure
A Randomized Controlled Trial for Patients With Heart Failure
Status: Enrolling
Updated: 6/26/2012
UCSF Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Antidepressant Efficacy of the Anticholinergic Scopolamine
The Antidepressant Efficacy of the Anticholinergic Scopolamine
Status: Enrolling
Updated:  6/28/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
The Antidepressant Efficacy of the Anticholinergic Scopolamine
The Antidepressant Efficacy of the Anticholinergic Scopolamine
Status: Enrolling
Updated: 6/28/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Therapy for Undergraduate College Students Who Binge Drink and Are Depressed
Treatment for Excessive Alcohol Use and Depression in Students (TREADS)
Status: Enrolling
Updated:  6/29/2012
Massachusetts General Hospital
mi
from
Boston, MA
Therapy for Undergraduate College Students Who Binge Drink and Are Depressed
Treatment for Excessive Alcohol Use and Depression in Students (TREADS)
Status: Enrolling
Updated: 6/29/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Antidepressant Adherence Via AD_IVR
Antidepressant Adherence Via Telephonic Interactive Voice Recognition (IVR)
Status: Enrolling
Updated:  7/2/2012
Kaiser Permanente Center for Health Research
mi
from
Portland, OR
Antidepressant Adherence Via AD_IVR
Antidepressant Adherence Via Telephonic Interactive Voice Recognition (IVR)
Status: Enrolling
Updated: 7/2/2012
Kaiser Permanente Center for Health Research
mi
from
Portland, OR
Click here to add this to my saved trials
Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression
Potential Use Of Brain Network Activation Analysis Using Evoked Response Potentials to Diagnose Major Depression and Assess Response to Antidepressant Treatment
Status: Enrolling
Updated:  7/2/2012
Depression Clinical and Research Program
mi
from
Boston, MA
Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression
Potential Use Of Brain Network Activation Analysis Using Evoked Response Potentials to Diagnose Major Depression and Assess Response to Antidepressant Treatment
Status: Enrolling
Updated: 7/2/2012
Depression Clinical and Research Program
mi
from
Boston, MA
Click here to add this to my saved trials
Ketamine Infusion for Treatment-resistant Major Depressive Disorder
N-methyl-D-aspartate Antagonist (Ketamine) Infusion for Treatment-resistant Major Depressive Disorder With Suicidal Ideation
Status: Enrolling
Updated:  7/2/2012
Depression Clinical and Research Program, MGH
mi
from
Boston, MA
Ketamine Infusion for Treatment-resistant Major Depressive Disorder
N-methyl-D-aspartate Antagonist (Ketamine) Infusion for Treatment-resistant Major Depressive Disorder With Suicidal Ideation
Status: Enrolling
Updated: 7/2/2012
Depression Clinical and Research Program, MGH
mi
from
Boston, MA
Click here to add this to my saved trials
The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)
Behavioral Treatment for Alcohol Dependent Women With Co-occurring Depression
Status: Enrolling
Updated:  7/11/2012
Univ of Rochester Medical Center
mi
from
Rochester, NY
The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)
Behavioral Treatment for Alcohol Dependent Women With Co-occurring Depression
Status: Enrolling
Updated: 7/11/2012
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Status: Enrolling
Updated:  7/12/2012
MGH Depression Clinical and Research Program
mi
from
Boston, MA
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Status: Enrolling
Updated: 7/12/2012
MGH Depression Clinical and Research Program
mi
from
Boston, MA
Click here to add this to my saved trials
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Little Rock, AR
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Los Angeles, CA
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Orange, CA
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
San Diego, CA
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Santa Ana, CA
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Hartford, CT
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Hartford, CT
Click here to add this to my saved trials
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
New Haven, CT
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Boca Raton, FL
AZD6765 Severe Major Depressive Disorder (MDD) IV
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials